IDBS and Alchemi partner to accelerate biopharma regulatory filings with compliant AI agents
Summary
Turtlemint has filed its red herring prospectus for an IPO and set a price band of Rs 144-152 per share. The issue is expected to raise about Rs 883 crore through a mix of fresh issuance and an offer for sale by founders and investors. The company plans to direct a large share of the proceeds toward technology and product development, along with cloud infrastructure and marketing. Turtlemint also reported strong revenue growth for the first nine months of FY26, though losses widened during the period.
Funding
Amount
-
Total raised
Date
-
Announcement date
Investors
ID Business Solutions, Danaher
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected